Prot # SB623: A Phase 1/2A Study of the Safety and Efficacy of Modified Stromal Cells(SB623) in Patients with Stable Ischemic Stroke

Project: Research project

Project Details

StatusFinished
Effective start/end date8/28/128/28/15

Funding

  • SanBio, Inc. (Prot # SB623)